DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b ) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the appl icant regards as his invention. Claims 3-8 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Each of claims 3 and 6 depends on claim 1. Claim 1 recites (last line) “a predetermined threshold”. Line 12 of claim 3 recites “a predetermined threshold”. Lines 10-11 of claim 6 recite “a predetermined threshold”. It is not clear, in each case, if this is the same predetermined threshold as recited in claim 1 or a different threshold. Claims 4-5 are rejected by virtue of their dependency on claim 3. Claims 7-8 are rejected by virtue of their dependency on claim 6. Allowable Subject Matter Claims 1-2 are allowed. The following is an examiner’s statement of reasons for allowance: Prior art fails to disclose a non-destructive inspection apparatus comprising: a first shutter configured to open and close the first opening of the first case; a first dose detector configured to detect a radioactive dose outside the first case; a second dose detector configured to detect a radioactive dose inside the first case; and a controller configured to prohibit opening of the first shutter, when the radioactive dose detected by at least one of the first dose detector or the second dose detector exceeds a predetermined threshold , as claimed in claim 1. Claim 2 is allowed by virtue of its dependency on claim 1. Any comments considered necessary by applicant must be submitted no later than the payment of the issue fee and, to avoid processing delays, should preferably accompany the issue fee. Such submissions should be clearly labeled “Comments on Statement of Reasons for Allowance.” Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to FILLIN "Examiner name" \* MERGEFORMAT JURIE YUN whose telephone number is FILLIN "Phone number" \* MERGEFORMAT (571)272-2497 . The examiner can normally be reached FILLIN "Work Schedule?" \* MERGEFORMAT 10:30 am - 7:30 pm . Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, FILLIN "SPE Name?" \* MERGEFORMAT David J Makiya can be reached at FILLIN "SPE Phone?" \* MERGEFORMAT 571 272-2273 . The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JURIE YUN/ Primary Examiner, Art Unit 2884 September 3, 2025